NOVACYT HALF YEAR 2017 RESULTS Consolidated sales growth +53% CER Group continues positive outlook for 2017

Novacyt half year 2017 results ENG Paris, France and Cambridge, UK – 16th August 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces unaudited reviewed financial results for the six months ended 30 June 2017.

Visit Page